True but every other biotech PPS increases as trials or other catalyst events are on the horizon. Unless of course they're being predicted doomed to fail by the street. Then you see the price action as we see with pmcb.
Quote: "Every company in Clinical Trials is waiting for something at whatever step they are at. The pps I just can't keep explaining."
Market Data 
Markets 
AI
